Market Cap 7.65M
Revenue (ttm) 43.79M
Net Income (ttm) -37.38M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -85.36%
Debt to Equity Ratio -1.46
Volume 11,200
Avg Vol 32,587
Day's Range N/A - N/A
Shares Out 813,000.00
Stochastic %K 10%
Beta 0.74
Analysts Strong Buy
Price Target $15.00

Company Profile

Trinity Biotech plc, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases, such as syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxopl...

Industry: Medical Devices
Sector: Healthcare
Phone: 353 1 276 9800
Address:
IDA Business Park, Bray, Ireland
Super5Investments
Super5Investments Aug. 28 at 10:56 PM
$TRIB garbage
0 · Reply
focafoca99
focafoca99 Aug. 28 at 10:39 PM
$TRIB noted a diagnostics business update and progress on its Nasdaq listing.
0 · Reply
deepthinker
deepthinker Aug. 27 at 2:07 PM
$TRIB If the CGM will be ready for trials in the next few months, as discussed in March, then the only question is funding. They pulled the SEPA, which was meant to provide funding for such trials, because they’ve acquired alternative funding from…where?
1 · Reply
deepthinker
deepthinker Aug. 26 at 3:40 PM
$TRIB So the two catalysts which could turn this around would be a CGM partnership agreement on favorable terms or a real (ie, paid) contract with Echelon. I believe the Perceptive $2.5 million was mostly for new investments, like Metabolomics, Epicapture, Novus, and Latch.
2 · Reply
Clydagh
Clydagh Aug. 26 at 8:41 AM
$TRIB It seems the $2.5M is Perceptives final dev stage cash injection. So, Trib must have visibility of fresh funds - almost certainly in conjunction with a major deal, likely CGM. Directly – funds that come with the deal or indirectly – a cash raise after the shares shoot up in value after such a deal. Likely both. Plus $4.6M from the Lucid ATM that is still untouched. We could have 3rd party investors lined up to take a stake post deal\share price rerating. When? Obviously, it was not going to happen in the week or two after the $2.5M or less would have been required. How long will $2.5M last? Based on Trib’s run rate cash burn the $2.5M should last until mid-late October. But, drop-dead date is Oct 1 so mid-late Sept looks most probable. Trinity is skint, they had less than $1M in the bank in each of May, June and July. But they were suddenly confident enough to scrap Yorkville and now make very expensive hires. Estimate – deal mid-late Sept with a major share re-rating > $40
1 · Reply
Think_Bigly
Think_Bigly Aug. 26 at 7:01 AM
$TRIB Power gets the chips running, but cooling KEEPS them running. https://x.com/FrankCurzio/status/2092232761373556937
0 · Reply
deepthinker
deepthinker Aug. 26 at 3:46 AM
$TRIB Same question as before: they pulled the SEPA which was going to fund CGM trials. Why? Now, they’re hiring the CGM team. But, one thing is missing: money.
0 · Reply
Clydagh
Clydagh Aug. 25 at 12:27 PM
$TRIB Mid-late Sept is now likely date for CGM+ launch. Meanwhile the CGM team is expnading for global launch and accreditation.
1 · Reply
deepthinker
deepthinker Aug. 22 at 5:54 PM
$TRIB So, why did they suddenly quit the SEPA? They suffered the downside but didn’t get the cash. Something else must be going on.
1 · Reply
Disrupter
Disrupter Aug. 21 at 7:55 PM
$TRIB The Yorkville line is gone, but the Perceptive structure alone is roughly 7x current outstanding ADS in additional potential supply, paced by the 9.9% blocker but not eliminated by it * Current ADS: ~813K * Perceptive convert + warrants: ~5.71M additional ADS * Pro forma: ~6.52M ADS * With other disclosed options/warrants/MiCo: roughly 6.6M ADS
3 · Reply
Latest News on TRIB
Trinity Biotech Registration statement: Registration filing

Aug 21, 2026, 8:00 AM EDT - 17 days ago

Trinity Biotech Registration statement: Registration filing


Trinity Biotech trading halted, news pending

2026-07-23T23:50:13.000Z - 6 weeks ago

Trinity Biotech trading halted, news pending


Trinity Biotech announces plan to implement ADS ratio change

2026-07-22T11:35:25.000Z - 6 weeks ago

Trinity Biotech announces plan to implement ADS ratio change


Trinity Biotech Earnings release: Q1 2026

Jun 18, 2026, 4:00 PM EDT - 2 months ago

Trinity Biotech Earnings release: Q1 2026


Trinity Biotech Slides: Q1 2026

Jun 18, 2026, 4:00 PM EDT - 2 months ago

Trinity Biotech Slides: Q1 2026


Trinity Biotech Registration statement: Registration filing

Jun 3, 2026, 8:00 AM EDT - 3 months ago

Trinity Biotech Registration statement: Registration filing


Trinity Biotech Registration statement: Registration filing

May 13, 2026, 8:00 AM EDT - 3 months ago

Trinity Biotech Registration statement: Registration filing


Trinity Biotech Registration statement: Registration filing

May 13, 2026, 8:00 AM EDT - 3 months ago

Trinity Biotech Registration statement: Registration filing


Trinity Biotech Annual report: Q4 2025

Apr 30, 2026, 7:00 AM EDT - 4 months ago

Trinity Biotech Annual report: Q4 2025


Trinity Biotech Slides: Q4 2025

Apr 30, 2026, 7:00 AM EDT - 4 months ago

Trinity Biotech Slides: Q4 2025


Trinity Biotech Provides Business and Trading Update

Mar 10, 2026, 7:45 AM EDT - 6 months ago

Trinity Biotech Provides Business and Trading Update


Trinity Biotech secures $25M standby equity purchase agreement

2026-02-25T14:14:32.000Z - 6 months ago

Trinity Biotech secures $25M standby equity purchase agreement


Trinity Biotech Registration statement: Registration filing

Feb 25, 2026, 7:00 AM EST - 6 months ago

Trinity Biotech Registration statement: Registration filing


Trinity Biotech receives noncompliance notification from Nasdaq

2026-02-20T22:10:49.000Z - 6 months ago

Trinity Biotech receives noncompliance notification from Nasdaq


Trinity Biotech receives noncompliance notification from Nasdaq

2026-02-13T22:10:18.000Z - 6 months ago

Trinity Biotech receives noncompliance notification from Nasdaq


Trinity Biotech files to sell 55.89M American depositary shares

2026-01-15T21:35:23.000Z - 7 months ago

Trinity Biotech files to sell 55.89M American depositary shares


Trinity Biotech Slides: Q3 2025

Dec 23, 2025, 9:30 AM EST - 8 months ago

Trinity Biotech Slides: Q3 2025


Trinity Biotech Slides: Q2 2025

Dec 23, 2025, 8:30 AM EST - 8 months ago

Trinity Biotech Slides: Q2 2025


Trinity Biotech Slides: Q1 2025

Jul 1, 2025, 7:00 AM EDT - 1 year ago

Trinity Biotech Slides: Q1 2025


Trinity Biotech Earnings release: Q4 2024

May 16, 2025, 6:00 AM EDT - 1 year ago

Trinity Biotech Earnings release: Q4 2024


Trinity Biotech Annual report: Q4 2024

May 16, 2025, 6:00 AM EDT - 1 year ago

Trinity Biotech Annual report: Q4 2024


Trinity Biotech Registration statement: Registration Filing

Mar 21, 2025, 8:00 AM EDT - 1 year ago

Trinity Biotech Registration statement: Registration Filing


Trinity Biotech Registration statement: Registration Filing

Nov 29, 2024, 7:00 AM EST - 1 year ago

Trinity Biotech Registration statement: Registration Filing


Trinity Biotech Earnings Call Transcript: Q3 2024

Nov 15, 2024, 10:00 AM EST - 1 year ago

Trinity Biotech Earnings Call Transcript: Q3 2024


Trinity Biotech Earnings release: Q3 2024

Nov 15, 2024, 10:00 AM EST - 1 year ago

Trinity Biotech Earnings release: Q3 2024


Trinity Biotech Announces Q3 2024 Financial Results

Nov 15, 2024, 9:00 AM EST - 1 year ago

Trinity Biotech Announces Q3 2024 Financial Results


Trinity Biotech Registration statement: Registration Filing

Nov 15, 2024, 7:00 AM EST - 1 year ago

Trinity Biotech Registration statement: Registration Filing


Trinity Biotech to Announce Q3 2024 Financial Results

Nov 14, 2024, 8:07 AM EST - 1 year ago

Trinity Biotech to Announce Q3 2024 Financial Results


Super5Investments
Super5Investments Aug. 28 at 10:56 PM
$TRIB garbage
0 · Reply
focafoca99
focafoca99 Aug. 28 at 10:39 PM
$TRIB noted a diagnostics business update and progress on its Nasdaq listing.
0 · Reply
deepthinker
deepthinker Aug. 27 at 2:07 PM
$TRIB If the CGM will be ready for trials in the next few months, as discussed in March, then the only question is funding. They pulled the SEPA, which was meant to provide funding for such trials, because they’ve acquired alternative funding from…where?
1 · Reply
deepthinker
deepthinker Aug. 26 at 3:40 PM
$TRIB So the two catalysts which could turn this around would be a CGM partnership agreement on favorable terms or a real (ie, paid) contract with Echelon. I believe the Perceptive $2.5 million was mostly for new investments, like Metabolomics, Epicapture, Novus, and Latch.
2 · Reply
Clydagh
Clydagh Aug. 26 at 8:41 AM
$TRIB It seems the $2.5M is Perceptives final dev stage cash injection. So, Trib must have visibility of fresh funds - almost certainly in conjunction with a major deal, likely CGM. Directly – funds that come with the deal or indirectly – a cash raise after the shares shoot up in value after such a deal. Likely both. Plus $4.6M from the Lucid ATM that is still untouched. We could have 3rd party investors lined up to take a stake post deal\share price rerating. When? Obviously, it was not going to happen in the week or two after the $2.5M or less would have been required. How long will $2.5M last? Based on Trib’s run rate cash burn the $2.5M should last until mid-late October. But, drop-dead date is Oct 1 so mid-late Sept looks most probable. Trinity is skint, they had less than $1M in the bank in each of May, June and July. But they were suddenly confident enough to scrap Yorkville and now make very expensive hires. Estimate – deal mid-late Sept with a major share re-rating > $40
1 · Reply
Think_Bigly
Think_Bigly Aug. 26 at 7:01 AM
$TRIB Power gets the chips running, but cooling KEEPS them running. https://x.com/FrankCurzio/status/2092232761373556937
0 · Reply
deepthinker
deepthinker Aug. 26 at 3:46 AM
$TRIB Same question as before: they pulled the SEPA which was going to fund CGM trials. Why? Now, they’re hiring the CGM team. But, one thing is missing: money.
0 · Reply
Clydagh
Clydagh Aug. 25 at 12:27 PM
$TRIB Mid-late Sept is now likely date for CGM+ launch. Meanwhile the CGM team is expnading for global launch and accreditation.
1 · Reply
deepthinker
deepthinker Aug. 22 at 5:54 PM
$TRIB So, why did they suddenly quit the SEPA? They suffered the downside but didn’t get the cash. Something else must be going on.
1 · Reply
Disrupter
Disrupter Aug. 21 at 7:55 PM
$TRIB The Yorkville line is gone, but the Perceptive structure alone is roughly 7x current outstanding ADS in additional potential supply, paced by the 9.9% blocker but not eliminated by it * Current ADS: ~813K * Perceptive convert + warrants: ~5.71M additional ADS * Pro forma: ~6.52M ADS * With other disclosed options/warrants/MiCo: roughly 6.6M ADS
3 · Reply
deepthinker
deepthinker Aug. 21 at 7:08 PM
$TRIB I’m assuming they did ATM on the day they first announced Trinivoum, and also that Perceptive sold some. Then, the stock collapsed because the market thought there was big dilution. But, there wasn’t? That’s why they didn’t get to MVPHS threshold?
1 · Reply
deepthinker
deepthinker Aug. 21 at 6:54 PM
$TRIB Wait, they barely used the SEPA. So, how many ADS are there right now. I’m confused.
0 · Reply
deepthinker
deepthinker Aug. 21 at 5:34 PM
$TRIB MedTech is suddenly getting hot again on sector rotation. So, timing is good if they actually have something.
0 · Reply
JustC6013
JustC6013 Aug. 20 at 1:38 PM
$TRIB Just sad
0 · Reply
m1ster_leboeuf
m1ster_leboeuf Aug. 19 at 3:41 PM
$TRIB 0.36/share pre split. Hilarious.
1 · Reply
Super5Investments
Super5Investments Aug. 18 at 11:29 PM
$TRIB All longterm shareholders have had their asses handed to them over the past 10 years.
2 · Reply
deepthinker
deepthinker Aug. 18 at 5:13 PM
$TRIB Still don’t know about MVPHS. Assuming they’re over now, I would expect that they’d be granted an extension if necessary. But, you never know.
1 · Reply
deepthinker
deepthinker Aug. 18 at 3:14 PM
$TRIB So, I think the way this goes is that Trinity has a starting fluid, pretty standard formulation. The selling point is that they can make small customizations and guarantee purity, lot tracing, etc. Since they’re nearby, this can be done quickly. Then, they’ll deliver it, monitor it, change it when necessary, recycle it. As this goes on, the two companies will be experimenting with fluid modification and Trinity will presumably be building an on-site monitoring device. What will change over time is that temperatures will rise, and cooling will take place at ever lower temperatures. So, Trinity will serve as Echelon’s experimental lab/research team. The goal would be to slowly expand to other regions.
1 · Reply
jeandaniel13
jeandaniel13 Aug. 18 at 3:00 PM
$TRIB 14 end of day
0 · Reply
deepthinker
deepthinker Aug. 17 at 7:49 PM
$TRIB Ok, so we’re waiting on MVPHS.
0 · Reply
jeandaniel13
jeandaniel13 Aug. 17 at 3:15 PM
$TRIB going to 25 soon
1 · Reply
deepthinker
deepthinker Aug. 17 at 1:56 PM
$TRIB Don’t know how many public shares , so don’t about MVPHS compliance.
1 · Reply